We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| MaxLinear Inc | NASDAQ:MXL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.7199 | 4.12% | 18.1899 | 17.65 | 18.19 | 18.21 | 16.91 | 17.41 | 4,310,962 | 23:56:29 |
From Aug 2024 to Feb 2025
MaxLinear, Inc. (Nasdaq: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced financial results for the third quarter ended September 30, 2024.
Third Quarter Financial Highlights
GAAP basis:
Non-GAAP basis:
Management Commentary
“We are pleased to see encouraging signs of recovery in our business, including another quarter of improvement in customer orders and continued progress in new product traction,” said Kishore Seendripu, PhD, Chairman and CEO. “In particular, we are on track to exit the year at a run rate greater than one million units per year of our high-speed optical interconnect products as customers prepare for the industry transition to 800Gig and beyond. In addition, design win activity and customer success in fiber PON gateways, Ethernet, storage, and Wi-Fi7 position us for renewed growth and earnings improvement in the fourth quarter and beyond.”
Fourth Quarter 2024 Business Outlook
The company expects net revenue in the fourth quarter of 2024 to be approximately $80 million to $100 million. The Company also estimates the following:
Webcast and Conference Call
MaxLinear will host its third quarter financial results conference call today, October 23, 2024 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-877-407-3109 / International: 1-201-493-6798. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at https://investors.maxlinear.com, and will be archived and available after the call at https://investors.maxlinear.com until November 6, 2024. A replay of the conference call will also be available until November 6, 2024 by dialing US toll free: 1-877-660-6853 / International: 1-201-612-7415 and Conference ID#: 13749152.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including our current guidance for fourth quarter 2024 net revenue, and GAAP and non-GAAP amounts for each of the following: gross margins, operating expenses, interest and other expenses, and diluted share counts); our potential growth and revenue opportunities; market trends; settlement of bonus awards for our 2024 performance period; and statements by our Chairman and CEO. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements and our future financial performance and operating results forecasts generally. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business, future operating results and financial condition include, without limitation; risks relating to our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages; the effect of intense and increasing competition; impacts of global economic conditions; the cyclical nature of the semiconductor industry; a significant variance in our operating results and impact on volatility in our stock price, and our ability to sustain our current level of revenue, which has declined, and/or manage future growth effectively, and the impact of excess inventory in the channel on our customers’ expected demand for certain of our products and on our revenue; the geopolitical and economic tensions among the countries in which we conduct business; increased tariffs, export controls or imposition of other trade barriers; our ability to obtain or retain government authorization to export certain of our products or technology; risks related to the loss of, or a significant reduction in orders from major customers; costs of legal proceedings or potential violations of regulations; information technology failures; a decrease in the average selling prices of our products; failure to penetrate new applications and markets; development delays and consolidation trends in our industry; inability to make substantial research and development investments; delays or expenses caused by undetected defects or bugs in our products; substantial quarterly and annual fluctuations in our revenue and operating results; failure to timely develop and introduce new or enhanced products; order and shipment uncertainties; failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes; customer product plan cancellations; failure to maintain compliance with government regulations; failure to attract and retain qualified personnel; any adverse impact of rising interest rates on us, our customers, and our distributors and related demand; risks related to compliance with privacy, data protection and cybersecurity laws and regulations; risks related to conforming our products to industry standards; risks related to business acquisitions and investments; claims of intellectual property infringement; our ability to protect our intellectual property; risks related to security vulnerabilities of our products; use of open source software in our products; and failure to manage our relationships with, or negative impacts from, third parties.
In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our Current Reports on Form 8-K, as well as the information to be set forth under the caption "Risk Factors" in MaxLinear's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024. All forward-looking statements are based on the estimates, projections and assumptions of management as of October 23, 2024, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.
Use of Non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating expenses as a percentage of net revenue, non-GAAP income (loss) from operations, non-GAAP income (loss) from operations as percentage of revenue, non-GAAP interest and other income (expense), non-GAAP diluted earnings (loss) per share, and non-GAAP diluted share count. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance-based bonus plan for 2024, which we intend to settle in shares of our common stock; (iii) accruals related to our performance-based bonus plan for 2023, which we settled in shares of common stock in February 2024; (iv) amortization of purchased intangible assets; (v) research and development funded by others; (vi) acquisition and integration costs related to our acquisitions, including costs incurred related to the termination of the previously pending (now terminated) merger with Silicon Motion; (vii) impairment of intangible assets; (viii) severance and other restructuring charges; (ix) other non-recurring interest and other income (expenses), net attributable to acquisitions, including impairment of investments in a privately held entity and ticking fees paid to lenders in August 2023 following the termination of the previously pending (now terminated) merger with Silicon Motion; and (x) non-cash income tax benefits and expenses. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP financial measures. Non-GAAP financial measures are subject to limitations, and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.
We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that we believe are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.
The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:
Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income or loss.
Performance-based equity consists of accruals related to our executive and non-executive bonus programs, and have been excluded from our non-GAAP net income or loss for all periods reported. Bonus payments for the 2023 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in February 2024. We currently expect that bonus awards under our fiscal 2024 program will be settled in common stock in the first quarter of fiscal 2025.
Expenses incurred in relation to acquisitions include amortization of purchased intangible assets, acquisition and integration costs primarily consisting of professional and consulting fees, including costs incurred related to the termination of the previously pending (now terminated) merger with Silicon Motion; ticking fees paid to lenders following the termination of such merger which were recorded in other expense; and accretion of discount on contingent consideration to interest expense.
Research and development funded by others represents proceeds received under contracts for jointly funded R&D projects to develop technology that may be commercialized into a product in the future. Initially such proceeds may not yet be recognized in GAAP results if, pursuant to contract terms, the Company may be required to repay all or a portion of the funds provided by the other party under certain conditions. Management believes it is not probable that it will trigger such conditions. Once such conditions have been resolved, the proceeds are recognized in GAAP results, and accordingly, reversed from non-GAAP results.
Impairment losses are related to abandonment of acquired or purchased intangible assets.
Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to impairment of leased right-of-use assets or from exiting certain facilities.
Other expense also includes losses from impairment of privately held investments.
Income tax benefits and expense adjustments are those that do not affect cash income taxes payable.
Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, we are also unable to predict their probable significance, particularly related to stock-based compensation and its related tax effects as well as potential impairments, a quantitative reconciliation is not available without unreasonable efforts and accordingly, in reliance on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, we have not provided a reconciliation for non-GAAP guidance provided for the fourth quarter 2024.
About MaxLinear, Inc.
MaxLinear, Inc. (Nasdaq:MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit www.maxlinear.com.
MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
Three Months Ended
September 30, 2024
June 30, 2024
September 30, 2023
Net revenue
$
81,102
$
91,990
$
135,530
Cost of net revenue
37,022
41,804
61,586
Gross profit
44,080
50,186
73,944
Operating expenses:
Research and development
52,604
56,541
66,306
Selling, general and administrative
30,154
33,600
25,402
Impairment losses
1,237
—
—
Restructuring charges
26,828
865
54
Total operating expenses
110,823
91,006
91,762
Loss from operations
(66,743
)
(40,820
)
(17,818
)
Interest income
1,653
1,871
1,736
Interest expense
(2,655
)
(2,706
)
(2,715
)
Other income (expense), net
(14,753
)
329
(22,721
)
Total other income (expense), net
(15,755
)
(506
)
(23,700
)
Loss before income taxes
(82,498
)
(41,326
)
(41,518
)
Income tax benefit
(6,713
)
(2,060
)
(1,689
)
Net loss
$
(75,785
)
$
(39,266
)
$
(39,829
)
Net loss per share:
Basic
$
(0.90
)
$
(0.47
)
$
(0.49
)
Diluted
$
(0.90
)
$
(0.47
)
$
(0.49
)
Shares used to compute net loss per share:
Basic
84,074
83,477
81,249
Diluted
84,074
83,477
81,249
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
Nine Months Ended
September 30, 2024
September 30, 2023
Net revenue
$
268,361
$
567,910
Cost of net revenue
124,827
250,786
Gross profit
143,534
317,124
Operating expenses:
Research and development
173,911
204,254
Selling, general and administrative
100,242
97,772
Impairment losses
1,237
2,438
Restructuring charges
50,323
9,138
Total operating expenses
325,713
313,602
Income (loss) from operations
(182,179
)
3,522
Interest income
5,346
4,272
Interest expense
(8,072
)
(7,793
)
Other income (expense), net
(12,990
)
(21,180
)
Total other income (expense), net
(15,716
)
(24,701
)
Loss before income taxes
(197,895
)
(21,179
)
Income tax provision (benefit)
(10,535
)
13,468
Net loss
$
(187,360
)
$
(34,647
)
Net loss per share:
Basic
$
(2.25
)
$
(0.43
)
Diluted
$
(2.25
)
$
(0.43
)
Shares used to compute net loss per share:
Basic
83,303
80,395
Diluted
83,303
80,395
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Three Months Ended
September 30, 2024
June 30, 2024
September 30, 2023
Operating Activities
Net loss
$
(75,785
)
$
(39,266
)
$
(39,829
)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation
12,142
13,600
17,014
Impairment of intangible assets
1,237
—
—
Impairment of investments and other assets
14,000
—
—
Amortization of debt issuance costs and accretion of discount on debt and leases
637
665
685
Stock-based compensation
12,788
17,359
5,118
Deferred income taxes
(8,320
)
(2,053
)
(2,384
)
Loss on disposal of property and equipment
623
55
16
Unrealized holding loss on investments
—
—
5,876
Impairment of leased right-of-use assets
677
700
—
(Gain) loss on extinguishment of lease liabilities
(1
)
16
—
Gain on settlement of pension
—
—
(1,008
)
(Gain) loss on foreign currency and other
2,339
(398
)
(13
)
Excess tax (benefits) deficiencies on stock based awards
(1,469
)
(152
)
769
Changes in operating assets and liabilities:
Accounts receivable, net
37,010
41,290
(2,398
)
Inventory
(1,325
)
1,387
11,210
Prepaid expenses and other assets
(7,852
)
1,281
(4,563
)
Accounts payable, accrued expenses and other current liabilities
(3,770
)
(24,280
)
9,347
Accrued compensation
159
(5,855
)
4,914
Accrued price protection liability
(17,158
)
(3,603
)
(11,995
)
Lease liabilities
(2,761
)
(2,540
)
(2,882
)
Other long-term liabilities
6,098
(902
)
(2,669
)
Net cash used in operating activities
(30,731
)
(2,696
)
(12,792
)
Investing Activities
Purchases of property and equipment
(4,132
)
(3,013
)
(1,927
)
Purchases of intangible assets
(1,818
)
(2,775
)
(674
)
Net cash used in investing activities
(5,950
)
(5,788
)
(2,601
)
Financing Activities
Payment of debt commitment fees
—
—
(18,325
)
Net proceeds from issuance of common stock
—
1,579
92
Minimum tax withholding paid on behalf of employees for restricted stock units
(58
)
447
(3,232
)
Net cash provided by (used in) financing activities
(58
)
2,026
(21,465
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
94
(335
)
(633
)
Decrease in cash, cash equivalents and restricted cash
(36,645
)
(6,793
)
(37,491
)
Cash, cash equivalents and restricted cash at beginning of period
186,137
192,930
225,643
Cash, cash equivalents and restricted cash at end of period
$
149,492
$
186,137
$
188,152
MAXLINEAR, INC.
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Nine Months Ended
September 30, 2024
September 30, 2023
Operating Activities
Net loss
$
(187,360
)
$
(34,647
)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Amortization and depreciation
42,426
54,923
Impairment of intangible assets
1,237
2,438
Impairment of investments and other assets
14,000
—
Amortization of debt issuance costs and accretion of discount on debt and leases
1,990
1,858
Stock-based compensation
47,208
38,763
Deferred income taxes
(13,058
)
6,502
Loss on disposal of property and equipment
1,068
2,057
Unrealized holding loss on investments
—
3,917
Impairment of leased right-of-use assets
3,415
—
Gain on settlement of pension
—
(1,008
)
Gain on extinguishment of lease liabilities
(554
)
—
Loss on foreign currency
973
140
Excess tax benefits on stock-based awards
(2,988
)
(529
)
Changes in operating assets and liabilities:
Accounts receivable, net
122,689
13,769
Inventory
3,845
45,602
Prepaid expenses and other assets
(8,615
)
(10,215
)
Accounts payable, accrued expenses and other current liabilities
(16,041
)
(17,917
)
Accrued compensation
3,011
8,776
Accrued price protection liability
(27,212
)
(45,036
)
Lease liabilities
(7,806
)
(8,891
)
Other long-term liabilities
4,315
(557
)
Net cash provided by (used in) operating activities
(17,457
)
59,945
Investing Activities
Purchases of property and equipment
(15,487
)
(12,180
)
Purchases of intangible assets
(4,961
)
(6,198
)
Cash used in acquisitions, net of cash acquired
—
(12,384
)
Net cash used in investing activities
(20,448
)
(30,762
)
Financing Activities
Payment of debt commitment fees
—
(18,325
)
Net proceeds from issuance of common stock
1,579
3,168
Minimum tax withholding paid on behalf of employees for restricted stock units
(1,714
)
(12,370
)
Net cash used in financing activities
(135
)
(27,527
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(824
)
(1,861
)
Decrease in cash, cash equivalents and restricted cash
(38,864
)
(205
)
Cash, cash equivalents and restricted cash at beginning of period
188,356
188,357
Cash, cash equivalents and restricted cash at end of period
$
149,492
$
188,152
MAXLINEAR, INC.
UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 30, 2024
June 30, 2024
September 30, 2023
Assets
Current assets:
Cash and cash equivalents
$
148,476
$
185,108
$
187,028
Short-term restricted cash
993
1,006
1,105
Short-term investments
—
—
14,612
Accounts receivable, net
47,930
84,940
158,232
Inventory
96,063
94,738
114,942
Prepaid expenses and other current assets
34,798
31,789
32,688
Total current assets
328,260
397,581
508,607
Long-term restricted cash
23
23
19
Property and equipment, net
63,493
65,422
69,484
Leased right-of-use assets
22,549
24,883
32,647
Intangible assets, net
58,031
61,786
82,643
Goodwill
318,588
318,588
318,456
Deferred tax assets
82,552
74,228
59,121
Other long-term assets
21,807
30,686
32,810
Total assets
$
895,303
$
973,197
$
1,103,787
Liabilities and stockholders’ equity
Current liabilities
$
168,597
$
190,277
$
232,910
Long-term lease liabilities
19,433
21,522
28,017
Long-term debt
122,840
122,684
122,219
Other long-term liabilities
27,561
21,459
17,964
Stockholders’ equity
556,872
617,255
702,677
Total liabilities and stockholders’ equity
$
895,303
$
973,197
$
1,103,787
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS
(in thousands, except per share data)
Three Months Ended
September 30, 2024
June 30, 2024
September 30, 2023
GAAP gross profit
$
44,080
$
50,186
$
73,944
Stock-based compensation
81
173
170
Performance based equity
(19
)
(37
)
19
Amortization of purchased intangible assets
3,498
5,089
8,332
Non-GAAP gross profit
47,640
55,411
82,465
GAAP R&D expenses
52,604
56,541
66,306
Stock-based compensation
(7,423
)
(10,088
)
(9,436
)
Performance based equity
775
1,789
(2,288
)
Research and development funded by others
3,000
—
(5,500
)
Non-GAAP R&D expenses
48,956
48,242
49,082
GAAP SG&A expenses
30,154
33,600
25,402
Stock-based compensation
(5,284
)
(7,097
)
4,488
Performance based equity
384
722
(999
)
Amortization of purchased intangible assets
(591
)
(592
)
(653
)
Acquisition and integration costs
(801
)
(102
)
(2,172
)
Non-GAAP SG&A expenses
23,862
26,531
26,066
GAAP impairment losses
1,237
—
—
Impairment losses
(1,237
)
—
—
Non-GAAP impairment losses
—
—
—
GAAP restructuring expenses
26,828
865
54
Restructuring charges
(26,828
)
(865
)
(54
)
Non-GAAP restructuring expenses
—
—
—
GAAP loss from operations
(66,743
)
(40,820
)
(17,818
)
Total non-GAAP adjustments
41,565
21,458
25,135
Non-GAAP income (loss) from operations
(25,178
)
(19,362
)
7,317
GAAP interest and other income (expense), net
(15,755
)
(506
)
(23,700
)
Non-recurring interest and other income (expense), net
11,769
65
18,395
Non-GAAP interest and other income (expense), net
(3,986
)
(441
)
(5,305
)
GAAP loss before income taxes
(82,498
)
(41,326
)
(41,518
)
Total non-GAAP adjustments
53,334
21,523
43,530
Non-GAAP income (loss) before income taxes
(29,164
)
(19,803
)
2,012
GAAP income tax benefit
(6,713
)
(2,060
)
(1,689
)
Adjustment for non-cash tax benefits/expenses
7,568
3,205
1,891
Non-GAAP income tax provision
855
1,145
202
GAAP net loss
(75,785
)
(39,266
)
(39,829
)
Total non-GAAP adjustments before income taxes
53,334
21,523
43,530
Less: total tax adjustments
7,568
3,205
1,891
Non-GAAP net income (loss)
$
(30,019
)
$
(20,948
)
$
1,810
Shares used in computing GAAP and non-GAAP basic net income (loss) per share
84,074
83,477
81,249
Shares used in computing GAAP diluted net loss per share
84,074
83,477
81,249
Dilutive common stock equivalents
—
—
719
Shares used in computing non-GAAP diluted net income (loss) per share
84,074
83,477
81,968
Non-GAAP basic net income (loss) per share
$
(0.36
)
$
(0.25
)
$
0.02
Non-GAAP diluted net income (loss) per share
$
(0.36
)
$
(0.25
)
$
0.02
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS
(in thousands, except per share data)
Nine months ended
September 30, 2024
September 30, 2023
GAAP gross profit
$
143,534
$
317,124
Stock-based compensation
435
626
Performance based equity
16
94
Amortization of purchased intangible assets
16,808
26,770
Non-GAAP gross profit
160,793
344,614
GAAP R&D expenses
173,911
204,254
Stock-based compensation
(27,952
)
(33,128
)
Performance based equity
(2,365
)
(5,650
)
Research and development funded by others
2,000
(7,500
)
Non-GAAP R&D expenses
145,594
157,976
GAAP SG&A expenses
100,242
97,772
Stock-based compensation
(18,820
)
(5,009
)
Performance based equity
(1,321
)
(2,550
)
Amortization of purchased intangible assets
(1,774
)
(2,290
)
Acquisition and integration costs
(1,567
)
(7,487
)
Non-GAAP SG&A expenses
76,760
80,436
GAAP impairment losses
1,237
2,438
Impairment losses
(1,237
)
(2,438
)
Non-GAAP impairment losses
—
—
GAAP restructuring expenses
50,323
9,138
Restructuring charges
(50,323
)
(9,138
)
Non-GAAP restructuring expenses
—
—
GAAP income (loss) from operations
(182,179
)
3,522
Total non-GAAP adjustments
120,618
102,680
Non-GAAP income (loss) from operations
(61,561
)
106,202
GAAP interest and other income (expense), net
(15,716
)
(24,701
)
Non-recurring interest and other income (expense), net
11,907
18,574
Non-GAAP interest and other income (expense), net
(3,809
)
(6,127
)
GAAP loss before income taxes
(197,895
)
(21,179
)
Total non-GAAP adjustments
132,525
121,254
Non-GAAP income (loss) before income taxes
(65,370
)
100,075
GAAP income tax provision (benefit)
(10,535
)
13,468
Adjustment for non-cash tax benefits/expenses
13,535
(3,460
)
Non-GAAP income tax provision
3,000
10,008
GAAP net loss
(187,360
)
(34,647
)
Total non-GAAP adjustments before income taxes
132,525
121,254
Less: total tax adjustments
13,535
(3,460
)
Non-GAAP net income (loss)
$
(68,370
)
$
90,067
Shares used in computing GAAP and non-GAAP basic net income (loss) per share
83,303
80,395
Shares used in computing GAAP diluted net loss per share
83,303
80,395
Dilutive common stock equivalents
—
1,279
Shares used in computing non-GAAP diluted net income (loss) per share
83,303
81,674
Non-GAAP basic net income (loss) per share
$
(0.82
)
$
1.12
Non-GAAP diluted net income (loss) per share
$
(0.82
)
$
1.10
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES AS A PERCENTAGE OF NET REVENUE
Three Months Ended
September 30, 2024
June 30, 2024
September 30, 2023
GAAP gross margin
54.4
%
54.6
%
54.6
%
Stock-based compensation
0.1
%
0.2
%
0.1
%
Performance based equity
—
%
—
%
—
%
Amortization of purchased intangible assets
4.3
%
5.5
%
6.2
%
Non-GAAP gross margin
58.7
%
60.2
%
60.8
%
GAAP R&D expenses
64.9
%
61.5
%
48.9
%
Stock-based compensation
(9.2
)%
(11.0
)%
(7.0
)%
Performance based equity
1.0
%
1.9
%
(1.7
)%
Research and development funded by others
3.7
%
—
%
(4.1
)%
Non-GAAP R&D expenses
60.4
%
52.4
%
36.2
%
GAAP SG&A expenses
37.2
%
36.5
%
18.7
%
Stock-based compensation
(6.5
)%
(7.7
)%
3.3
%
Performance based equity
0.5
%
0.8
%
(0.7
)%
Amortization of purchased intangible assets
(0.7
)%
(0.6
)%
(0.5
)%
Acquisition and integration costs
(1.0
)%
(0.1
)%
(1.6
)%
Non-GAAP SG&A expenses
29.4
%
28.8
%
19.2
%
GAAP impairment losses
1.5
%
—
%
—
%
Impairment losses
(1.5
)%
—
%
—
%
Non-GAAP impairment losses
—
%
—
%
—
%
GAAP restructuring expenses
33.1
%
0.9
%
—
%
Restructuring charges
(33.1
)%
(0.9
)%
—
%
Non-GAAP restructuring expenses
—
%
—
%
—
%
GAAP loss from operations
(82.3
)%
(44.4
)%
(13.2
)%
Total non-GAAP adjustments
51.3
%
23.3
%
18.6
%
Non-GAAP income (loss) from operations
(31.0
)%
(21.0
)%
5.4
%
GAAP interest and other income (expense), net
(19.4
)%
(0.6
)%
(17.5
)%
Non-recurring interest and other income (expense), net
14.5
%
0.1
%
13.6
%
Non-GAAP interest and other income (expense), net
(4.9
)%
(0.5
)%
(3.9
)%
GAAP loss before income taxes
(101.7
)%
(44.9
)%
(30.6
)%
Total non-GAAP adjustments before income taxes
65.8
%
23.4
%
32.1
%
Non-GAAP income (loss) before income taxes
(36.0
)%
(21.5
)%
1.5
%
GAAP income tax benefit
(8.3
)%
(2.2
)%
(1.3
)%
Adjustment for non-cash tax benefits/expenses
9.3
%
3.5
%
1.4
%
Non-GAAP income tax provision
1.1
%
1.2
%
0.2
%
GAAP net loss
(93.4
)%
(42.7
)%
(29.4
)%
Total non-GAAP adjustments before income taxes
65.8
%
23.4
%
32.1
%
Less: total tax adjustments
9.3
%
3.5
%
1.4
%
Non-GAAP net income (loss)
(37.0
)%
(22.8
)%
1.3
%
MAXLINEAR, INC.
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES AS A PERCENTAGE OF NET REVENUE
Nine months ended
September 30, 2024
September 30, 2023
GAAP gross margin
53.5
%
55.8
%
Stock-based compensation
0.2
%
0.1
%
Performance based equity
—
%
—
%
Amortization of purchased intangible assets
6.3
%
4.7
%
Non-GAAP gross margin
59.9
%
60.7
%
GAAP R&D expenses
64.8
%
36.0
%
Stock-based compensation
(10.4
)%
(5.8
)%
Performance based equity
(0.9
)%
(1.0
)%
Research and development funded by others
0.8
%
(1.3
)%
Non-GAAP R&D expenses
54.3
%
27.8
%
GAAP SG&A expenses
37.4
%
17.2
%
Stock-based compensation
(7.0
)%
(0.9
)%
Performance based equity
(0.5
)%
(0.5
)%
Amortization of purchased intangible assets
(0.7
)%
(0.4
)%
Acquisition and integration costs
(0.6
)%
(1.3
)%
Non-GAAP SG&A expenses
28.6
%
14.2
%
GAAP impairment losses
0.5
%
0.4
%
Impairment losses
(0.5
)%
(0.4
)%
Non-GAAP impairment losses
—
%
—
%
GAAP restructuring expenses
18.8
%
1.6
%
Restructuring charges
(18.8
)%
(1.6
)%
Non-GAAP restructuring expenses
—
%
—
%
GAAP income (loss) from operations
(67.9
)%
0.6
%
Total non-GAAP adjustments
45.0
%
18.1
%
Non-GAAP income (loss) from operations
(22.9
)%
18.7
%
GAAP interest and other income (expense), net
(5.9
)%
(4.4
)%
Non-recurring interest and other income (expense), net
4.4
%
3.3
%
Non-GAAP interest and other income (expense), net
(1.4
)%
(1.1
)%
GAAP loss before income taxes
(73.7
)%
(3.7
)%
Total non-GAAP adjustments
49.4
%
21.4
%
Non-GAAP income (loss) before income taxes
(24.4
)%
17.6
%
GAAP income tax provision (benefit)
(3.9
)%
2.4
%
Adjustment for non-cash tax benefits/expenses
5.0
%
(0.6
)%
Non-GAAP income tax provision
1.1
%
1.8
%
GAAP net loss
(69.8
)%
(6.1
)%
Total non-GAAP adjustments before income taxes
49.4
%
21.4
%
Less: total tax adjustments
5.0
%
(0.6
)%
Non-GAAP net income (loss)
(25.5
)%
15.9
%
View source version on businesswire.com: https://www.businesswire.com/news/home/20241023178785/en/
MaxLinear, Inc. Investor Relations Contact:
Leslie Green Tel: +1 650-312-9060 lgreen@maxlinear.com
1 Year MaxLinear Chart |
1 Month MaxLinear Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
